Instilación intrapleural de activador tisular de plasminógeno y de deoxirribonucleasa recombinante humana en el empiema pleural. Visits. Download PDF. Se colocó un catéter en el extremo aórtico de la fístula y se instauró, a su través, tratamiento con activador recombinante tisular del plasminógeno (r-TPA) en. activator in vascular warning syndromesTrombólisis intravenosa con activador tisular del plasminógeno recombinante en los síndromes de alarma vascular☆.
|Published (Last):||2 November 2007|
|PDF File Size:||8.1 Mb|
|ePub File Size:||17.4 Mb|
|Price:||Free* [*Free Regsitration Required]|
Nine issues are published each year, including mostly originals, reviews and consensus documents.
SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field. The incidence of cardiac thrombi in newborns has increased with the use of central venous catheters.
Recombinant tissue plasminogen activator for actovador management of intracardiac thrombi in newborns. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal’s impact.
Activador del plasminógeno tisular recombinante en el manejo de trombos cardiacos en recién nacidos
Recombiante to our Newsletter. To improve our services and products, we use “cookies” own or third parties authorized to show advertising related to client preferences through the analyses of navigation customer behavior. Subscriber If you already have your login data, please click here.
The superior vena cava was the most frequent location, with a mean time of installation before the diagnosis of 12 days. Previous article Next article. In 4 patients complete resolution of the thrombus was achieved in a mean of 3. The patients included 4 males with a mean weight of gr. Four patients had intracranial haemorrhage grade I, without sequelae at follow-up.
From Monday to Friday from 9 a.
CiteScore measures average citations received per document published. Si continua navegando, consideramos que acepta su uso.
There was a problem providing the content you requested
March Pages ee24 Pages Continuing navigation will be considered as drl of this use. The aim of this study is to describe the response and complications related to the use of rTPA in the management of life- threatening cardiac thrombi in newborns.
Are you a health professional able to prescribe or dispense drugs? The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two receding years. Three patients received low molecular weight heparin prior to using rTPA.
SRJ is a prestige metric based on the idea that not all citations are the same. Print Send to a friend Export reference Mendeley Statistics.
Thrombolysis with recombinant tissue plasminogen activator rTPA has been used as an alternative to heparin in life threatening giant thrombus and embolization. The journal fully endorses the goals of updating knowledge and facilitating the acquisition of key developments in internal medicine applied to clinical practice. Intracardiac thrombi; Neonatal thrombolysis; Recombinant tissue plasminogen activator. They received between 1 to 5 cycles with rTPA. There were no deaths or embolism.
The medical records of 8 newborn were reviewed in a retrospective study, of whom 7 aftivador preterm with cardiac thrombi, and rTPA was used in all of them.
This item has received. You can change the settings or obtain more information by clicking here.